Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment

TORONTO, ON / ACCESSWIRE / April 2, 2024 / Lumira Ventures is delighted to announce its latest investment in Nocion Therapeutics, a clinical-stage biopharmaceutical company developing first and potentially best-in-class,

Related Keywords

Toronto ,Ontario ,Canada ,Lu Han , ,Lumira Ventures ,Nocion Therapeutics ,Taplucanium Dry Powder ,Chronic Cough ,